Grygiel Nancy A.
SEC CIK 1816414 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | SVP, CCO | 8,340 | — | $4.91M | 45 | 2021-11-05 | 2026-08-06 |
Most active insiders at AMGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Santos Esteban | EVP, Ops | — | $20.77M |
| 2 | Grygiel Nancy A. | SVP, CCO | — | $2.65M |
| 3 | Gordon Murdo | EVP, Gbl Commercial Ops | — | $2.32M |
| 4 | Khosla Rachna | SVP, Business Development | — | $1.65M |
| 5 | Miller Derek | SVP, Human Resources | — | $1.57M |
| 6 | Busch Matthew C. | VP, CAO, Fin | — | $375.8K |
| 7 | Klotman Mary E. | Dir | — | — |
| 8 | Bradner James E. | EVP, Research, Development | — | — |
| 9 | Drake Michael V | Dir | — | — |
| 10 | Griffith Peter H. | EVP, CFO | — | — |
Transactions 45
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-07 18:45 | 2026-08-06 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | M - OptEx | $177.41 | +2,970 | 8,340 | +55% | +$526.9K |
| DM | 2026-08-07 18:45 | 2026-08-06 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | S - Sale+OE | $402.16 | -2,970 | 7,340 | -29% | -$1.19M |
| 2026-05-11 20:02 | 2026-05-07 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $331.11 | -88 | 7,330 | -1% | -$29.1K | |
| D | 2026-05-07 20:54 | 2026-05-05 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | A - Grant | $0.00 | +485 | 7,494 | +7% | $0 |
| D | 2026-05-07 20:54 | 2026-05-06 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $329.59 | -76 | 7,418 | -1% | -$25.0K |
| M | 2026-05-05 20:09 | 2026-05-02 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $329.82 | -242 | 8,246 | -3% | -$79.8K |
| 2026-05-05 20:09 | 2026-05-04 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | S - Sale | $323.73 | -1,237 | 7,009 | -15% | -$400.5K | |
| 2026-03-18 | 2026-03-16 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $366.21 | -787 | 8,488 | -8% | -$288.2K | |
| 2026-03-05 | 2026-03-03 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | A - Grant | $0.00 | +2,010 | 9,249 | +28% | $0 | |
| DM | 2025-11-21 | 2025-11-20 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | S - Sale+OE | $337.26 | -3,139 | 7,225 | -30% | -$1.06M |
| DM | 2025-11-21 | 2025-11-20 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | M - OptEx | $169.70 | +3,139 | 8,864 | +55% | +$532.7K |
| 2025-08-22 | 2025-08-20 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | S - Sale | $296.99 | -1,267 | 7,209 | -15% | -$376.3K | |
| D | 2025-05-08 | 2025-05-06 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | A - Grant | $0.00 | +591 | 8,463 | +8% | $0 |
| M | 2025-05-06 | 2025-05-02 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $283.78 | -229 | 7,872 | -3% | -$65.0K |
| 2025-05-02 | 2025-04-30 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $288.56 | -113 | 8,101 | -1% | -$32.6K | |
| 2025-03-19 | 2025-03-17 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $313.71 | -524 | 8,214 | -6% | -$164.4K | |
| 2025-03-05 | 2025-03-03 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | A - Grant | $0.00 | +1,503 | 8,713 | +21% | $0 | |
| 2025-02-06 | 2025-02-05 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | S - Sale | $304.47 | -1,589 | 7,210 | -18% | -$483.8K | |
| 2024-07-31 | 2024-07-31 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $333.28 | -1,565 | 8,771 | -15% | -$521.6K | |
| D | 2024-05-09 | 2024-05-07 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | A - Grant | $0.00 | +499 | 10.3K | +5% | $0 |
| 2024-05-07 | 2024-05-05 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $311.29 | -82 | 9,801 | -0.8% | -$25.5K | |
| 2024-05-03 | 2024-05-03 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | S - Sale | $313.09 | -2,117 | 9,883 | -18% | -$662.8K | |
| 2024-05-03 | 2024-05-02 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $277.37 | -114 | 12.0K | -0.9% | -$31.6K | |
| 2024-05-01 | 2024-04-30 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $276.38 | -106 | 12.1K | -0.9% | -$29.3K | |
| 2024-03-20 | 2024-03-18 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $268.87 | -703 | 12.2K | -5% | -$189.0K | |
| 2024-03-08 | 2024-03-06 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | A - Grant | $0.00 | +1,954 | 12.9K | +18% | $0 | |
| 2023-12-04 | 2023-12-04 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | S - Sale | $273.03 | -2,096 | 10.9K | -16% | -$572.3K | |
| 2023-11-07 | 2023-11-05 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $269.86 | -249 | 13.0K | -2% | -$67.2K | |
| 2023-07-31 | 2023-07-31 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $236.37 | -1,129 | 13.1K | -8% | -$266.9K | |
| 2023-05-09 | 2023-05-05 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $231.89 | -54 | 14.2K | -0.4% | -$12.5K | |
| D | 2023-05-04 | 2023-05-03 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $235.97 | -62 | 14.3K | -0.4% | -$14.6K |
| D | 2023-05-04 | 2023-05-02 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | A - Grant | $0.00 | +635 | 14.3K | +5% | $0 |
| 2023-05-02 | 2023-04-30 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $239.74 | -73 | 13.7K | -0.5% | -$17.5K | |
| 2023-03-20 | 2023-03-17 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $234.57 | -339 | 13.8K | -2% | -$79.5K | |
| 2023-03-08 | 2023-03-06 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | A - Grant | $0.00 | +968 | 14.0K | +7% | $0 | |
| 2022-11-08 | 2022-11-08 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | S - Sale | $293.54 | -545 | 13.0K | -4% | -$160.0K | |
| 2022-11-08 | 2022-11-05 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $269.04 | -240 | 13.6K | -2% | -$64.6K | |
| 2022-08-02 | 2022-07-31 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $247.47 | -1,229 | 13.7K | -8% | -$304.1K | |
| 2022-05-09 | 2022-05-05 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $236.10 | -52 | 14.9K | -0.3% | -$12.3K | |
| D | 2022-05-04 | 2022-05-02 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | A - Grant | $0.00 | +649 | 15.0K | +5% | $0 |
| D | 2022-05-04 | 2022-05-02 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $230.92 | -57 | 14.9K | -0.4% | -$13.2K |
| 2022-04-29 | 2022-04-27 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $249.87 | -60 | 14.3K | -0.4% | -$15.0K | |
| 2022-03-22 | 2022-03-18 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | F - Tax | $235.86 | -350 | 14.4K | -2% | -$82.6K | |
| 2022-03-03 | 2022-03-01 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | A - Grant | $0.00 | +1,001 | 14.6K | +7% | $0 | |
| 2021-11-09 | 2021-11-05 | AMGN | Amgen | Grygiel Nancy A. | SVP, CCO | A - Grant | $0.00 | +935 | 13.5K | +7% | $0 |
Purchase Sale Sale after option exercise All abbreviations